0      0

eSymposia | Tuberculosis: Science Aimed at Ending the Epidemic

Short Talk: The Next Generation Diarylquinoline TBAJ 587 has Superior Efficacy Against, and Restricts Selection of, Bedaquiline Resistant Rv0678 Mutants in a Mouse Model of Tuberculosis


Dec 4, 2020 12:24pm ‐ Dec 4, 2020 12:36pm


Speaker(s):

You must be logged in and own this session in order to post comments.